FDA issued a Warning Letter to Pfizer Healthcare India Private Limited on 3/25/2020 for a later inspection.
483 Hospira Healthcare India Private Sep 2015

483 Hospira Healthcare India Private Sep 2015

Angela Glenn FDA, Daniel Roberts FDA, Santos Camara FDA$119.00 - Available Now

FDA investigators audited the Hospira Healthcare India Private - Visakhapatnam, India facility and issued 9 inspectional observations (via FDA 483) on 08 Sep 2015.

Product details

  • Category: Human Drugs
  • Number of Observations: 9
  • Inspection end: 08 Sep 2015
  • Location: Visakhapatnam, India
  • FEI: 3008316085
Add To Cart